{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:40:02Z","timestamp":1792287602242,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570662"],"award-info":[{"award-number":["82570662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970498"],"award-info":[{"award-number":["81970498"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ22H030002"],"award-info":[{"award-number":["LZ22H030002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10120-025-01678-8","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T11:23:15Z","timestamp":1760786595000},"page":"192-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Helicobacter pylori-na\u00efve status is associated with poor prognosis and aggressive pathological features in undifferentiated-type gastric cancer: a multi-center retrospective cohort study"],"prefix":"10.1007","volume":"29","author":[{"given":"Yuxuan","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yide","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8401-4001","authenticated-orcid":false,"given":"Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"issue":"3","key":"1678_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1678_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"Japanese Gastric Cancer Association","year":"2011","unstructured":"Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101\u201312. https:\/\/doi.org\/10.1007\/s10120-011-0041-5.","journal-title":"Gastric Cancer"},{"issue":"7","key":"1678_CR3","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/1097-0142(20001001)89:7<1418::AID-CNCR2>3.0.CO;2-A","volume":"89","author":"Y Adachi","year":"2000","unstructured":"Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, Kitano S. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer. 2000;89(7):1418\u201324.","journal-title":"Cancer"},{"issue":"11","key":"1678_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1056\/NEJMoa001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"1678_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000339176","volume":"86","author":"S Ono","year":"2012","unstructured":"Ono S, Kato M, Suzuki M, Ishigaki S, Takahashi M, Haneda M, et al. Frequency of Helicobacter pylori-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion. 2012;86(1):59\u201365. https:\/\/doi.org\/10.1159\/000339176.","journal-title":"Digestion"},{"issue":"5","key":"1678_CR6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1523-5378.2011.00859.x","volume":"16","author":"H Yoon","year":"2011","unstructured":"Yoon H, Kim N, Lee HS, Shin CM, Park YS, Lee DH, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics: H. pylori-negative gastric cancer. Helicobacter. 2011;16(5):382\u20138. https:\/\/doi.org\/10.1111\/j.1523-5378.2011.00859.x.","journal-title":"Helicobacter"},{"issue":"4","key":"1678_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00428-021-03237-9","volume":"480","author":"K Shibagaki","year":"2022","unstructured":"Shibagaki K, Itawaki A, Miyaoka Y, Kishimoto K, Takahashi Y, Kotani S, et al. Intestinal-type gastric dysplasia in Helicobacter pylori-na\u00efve patients. Virchows Arch. 2022;480(4):783\u201392. https:\/\/doi.org\/10.1007\/s00428-021-03237-9.","journal-title":"Virchows Arch"},{"issue":"8","key":"1678_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/jnci\/djac085","volume":"114","author":"Y Koizumi","year":"2022","unstructured":"Koizumi Y, Ahmad S, Ikeda M, Yashima-Abo A, Espina G, Sugimoto R, et al. Helicobacter pylori modulated host immunity in gastric cancer patients with S-1 adjuvant chemotherapy. JNCI J Natl Cancer Inst. 2022;114(8):1149\u201358. https:\/\/doi.org\/10.1093\/jnci\/djac085.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"4","key":"1678_CR9","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1245\/s10434-015-4953-x","volume":"23","author":"LM Postlewait","year":"2016","unstructured":"Postlewait LM, Squires MH, Kooby DA, Poultsides GA, Weber SM, Bloomston M, et al. Preoperative Helicobacter pylori infection is associated with increased survival after resection of gastric adenocarcinoma. Ann Surg Oncol. 2016;23(4):1225\u201333. https:\/\/doi.org\/10.1245\/s10434-015-4953-x.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"1678_CR10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/ijc.26081","volume":"130","author":"SY Kang","year":"2012","unstructured":"Kang SY, Han JH, Ahn MS, Lee HW, Jeong SH, Park JS, et al. Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection. Int J Cancer. 2012;130(4):948\u201358. https:\/\/doi.org\/10.1002\/ijc.26081.","journal-title":"Int J Cancer"},{"issue":"1","key":"1678_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-023-02050-2","volume":"59","author":"S Kotani","year":"2024","unstructured":"Kotani S, Shibagaki K, Hirahara N, Tanabe R, Ebisutani Y, Nonomura S, et al. Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -na\u00efve patients: a multicenter retrospective analysis. J Gastroenterol. 2024;59(1):1\u201310. https:\/\/doi.org\/10.1007\/s00535-023-02050-2.","journal-title":"J Gastroenterol"},{"issue":"1","key":"1678_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s10120-014-0452-1","volume":"19","author":"Y Horiuchi","year":"2016","unstructured":"Horiuchi Y, Fujisaki J, Yamamoto N, Shimizu T, Miyamoto Y, Tomida H, et al. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer. 2016;19(1):160\u20135. https:\/\/doi.org\/10.1007\/s10120-014-0452-1.","journal-title":"Gastric Cancer"},{"issue":"4","key":"1678_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000481817","volume":"96","author":"Y Horiuchi","year":"2017","unstructured":"Horiuchi Y, Fujisaki J, Ishizuka N, Omae M, Ishiyama A, Yoshio T, et al. Study on clinical factors involved in Helicobacter pylori-uninfected, undifferentiated-type early gastric cancer. Digestion. 2017;96(4):213\u20139. https:\/\/doi.org\/10.1159\/000481817.","journal-title":"Digestion"},{"issue":"5","key":"1678_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/jso.24977","volume":"117","author":"SS Nishizuka","year":"2018","unstructured":"Nishizuka SS, Tamura G, Nakatochi M, Fukushima N, Ohmori Y, Sumida C, et al. Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy. J Surg Oncol. 2018;117(5):947\u201356. https:\/\/doi.org\/10.1002\/jso.24977.","journal-title":"J Surg Oncol"},{"issue":"1","key":"1678_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/den.13883","volume":"33","author":"H Ono","year":"2021","unstructured":"Ono H, Yao K, Fujishiro M, Oda I, Uedo N, Nimura S, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33(1):4\u201320. https:\/\/doi.org\/10.1111\/den.13883.","journal-title":"Dig Endosc"},{"issue":"2","key":"1678_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5009\/gnl230106","volume":"18","author":"Y Horiuchi","year":"2024","unstructured":"Horiuchi Y, Hirasawa T, Fujisaki J. Endoscopic features of undifferentiated-type early gastric cancer in patients with Helicobacter pylori-uninfected or -eradicated stomachs: a comprehensive review. Gut Liver. 2024;18(2):209\u201317. https:\/\/doi.org\/10.5009\/gnl230106.","journal-title":"Gut Liver"},{"issue":"6","key":"1678_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1523-5378.2007.00549.x","volume":"12","author":"L Veijola","year":"2007","unstructured":"Veijola L, Oksanen A, Linnala A, Sipponen P, Rautelin H. Persisting chronic gastritis and elevated Helicobacter pylori antibodies after successful eradication therapy. Helicobacter. 2007;12(6):605\u20138. https:\/\/doi.org\/10.1111\/j.1523-5378.2007.00549.x.","journal-title":"Helicobacter"},{"issue":"6","key":"1678_CR18","doi-asserted-by":"publisher","first-page":"e39199","DOI":"10.1371\/journal.pone.0039199","volume":"7","author":"V Serelli-Lee","year":"2012","unstructured":"Serelli-Lee V, Ling KL, Ho C, Yeong LH, Lim GK, Ho B, et al. Persistent Helicobacter pylori specific Th17 responses in patients with past H. pylori infection are associated with elevated gastric mucosal IL-1\u03b2. PLoS ONE. 2012;7(6):e39199. https:\/\/doi.org\/10.1371\/journal.pone.0039199.","journal-title":"PLoS ONE"},{"issue":"2","key":"1678_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH688>3.0.CO;2-D","volume":"192","author":"T Kikuchi","year":"2000","unstructured":"Kikuchi T, Kato K, Ohara S, Sekine H, Arikawa T, Suzuki T, et al. The relationship between persistent secretion of RANTES and residual infiltration of eosinophils and memory T lymphocytes after Helicobacter pylori eradication. J Pathol. 2000;192(2):243\u201350. https:\/\/doi.org\/10.1002\/1096-9896(2000)9999:9999%3c::AID-PATH688%3e3.0.CO;2-D.","journal-title":"J Pathol"},{"issue":"4","key":"1678_CR20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1078-0432.CCR-11-2011","volume":"18","author":"T Ushijima","year":"2012","unstructured":"Ushijima T, Hattori N. Molecular pathways: involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers. Clin Cancer Res. 2012;18(4):923\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2011.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1678_CR21","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/j.1572-0241.2001.03869.x","volume":"96","author":"B Pignatelli","year":"2001","unstructured":"Pignatelli B, Bancel B, Plummer M, Toyokuni S, Patricot LM, Ohshima H. Helicobacter pylori eradication attenuates oxidative stress in human gastric mucosa. Am J Gastroenterol. 2001;96(6):1758\u201366. https:\/\/doi.org\/10.1111\/j.1572-0241.2001.03869.x.","journal-title":"Am J Gastroenterol"},{"issue":"10\u201312","key":"1678_CR22","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00011-021-01501-x","volume":"70","author":"H Yang","year":"2021","unstructured":"Yang H, Wei B, Hu B. Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer. Inflamm Res. 2021;70(10\u201312):1015\u201326. https:\/\/doi.org\/10.1007\/s00011-021-01501-x.","journal-title":"Inflamm Res"},{"key":"1678_CR23","doi-asserted-by":"publisher","first-page":"621879","DOI":"10.3389\/fmicb.2020.621879","volume":"11","author":"CM Shin","year":"2021","unstructured":"Shin CM, Kim N, Park JH, Lee DH. Changes in gastric corpus microbiota with age and after Helicobacter pylori eradication: a long-term follow-up study. Front Microbiol. 2021;11:621879. https:\/\/doi.org\/10.3389\/fmicb.2020.621879.","journal-title":"Front Microbiol"},{"issue":"7","key":"1678_CR24","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/j.1572-0241.2007.01284.x","volume":"102","author":"F Perri","year":"2007","unstructured":"Perri F, Cotugno R, Piepoli A, Merla A, Quitadamo M, Gentile A, et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am J Gastroenterol. 2007;102(7):1361\u201371. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01284.x.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1678_CR25","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/ijc.28219","volume":"133","author":"CM Shin","year":"2013","unstructured":"Shin CM, Kim N, Lee HS, Park JH, Ahn S, Kang GH, et al. Changes in aberrant DNA methylation after Helicobacter pylori eradication: a long-term follow-up study. Int J Cancer. 2013;133(9):2034\u201342. https:\/\/doi.org\/10.1002\/ijc.28219.","journal-title":"Int J Cancer"},{"key":"1678_CR26","volume-title":"TNM classification of malignant tumours","author":"JD Brierley","year":"2016","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. New York: Wiley; 2016.","edition":"8"},{"issue":"8","key":"1678_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1503\/cmaj.101715","volume":"184","author":"MJ Knol","year":"2012","unstructured":"Knol MJ, Le Cessie S, Algra A, Vandenbroucke JP, Groenwold RHH. Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression. CMAJ. 2012;184(8):895\u20139. https:\/\/doi.org\/10.1503\/cmaj.101715.","journal-title":"CMAJ"},{"issue":"10","key":"1678_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","volume":"59","author":"ART Donders","year":"2006","unstructured":"Donders ART, van der Heijden GJMG, Stijnen T, Moons KGM. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087\u201391. https:\/\/doi.org\/10.1016\/j.jclinepi.2006.01.014.","journal-title":"J Clin Epidemiol"},{"issue":"18","key":"1678_CR29","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1001\/jama.2015.15281","volume":"314","author":"P Li","year":"2015","unstructured":"Li P, Stuart EA, Allison DB. Multiple imputation: a flexible tool for handling missing data. JAMA. 2015;314(18):1966\u20137. https:\/\/doi.org\/10.1001\/jama.2015.15281.","journal-title":"JAMA"},{"issue":"6","key":"1678_CR30","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1213\/ANE.0000000000005773","volume":"133","author":"P Schober","year":"2021","unstructured":"Schober P, Mascha EJ, Vetter TR. Statistics from a (agreement) to z (z score): a guide to interpreting common measures of association, agreement, diagnostic accuracy, effect size, heterogeneity, and reliability in medical research. Anesth Analg. 2021;133(6):1633\u201341. https:\/\/doi.org\/10.1213\/ANE.0000000000005773.","journal-title":"Anesth Analg"},{"issue":"9","key":"1678_CR31","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1111\/jgh.12605","volume":"29","author":"HW Kwak","year":"2014","unstructured":"Kwak HW, Choi IJ, Cho SJ, Lee JY, Kim CG, Kook MC, et al. Characteristics of gastric cancer according to Helicobacter pylori infection status. J Gastroenterol Hepatol. 2014;29(9):1671\u20137. https:\/\/doi.org\/10.1111\/jgh.12605.","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"1678_CR32","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/cncr.24253","volume":"115","author":"D Marrelli","year":"2009","unstructured":"Marrelli D, Pedrazzani C, Berardi A, Corso G, Neri A, Garosi L, et al. Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer. 2009;115(10):2071\u201380. https:\/\/doi.org\/10.1002\/cncr.24253.","journal-title":"Cancer"},{"issue":"3","key":"1678_CR33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1470-2045(06)70586-1","volume":"7","author":"G Meimarakis","year":"2006","unstructured":"Meimarakis G, Winter H, Assmann I, Kopp R, Lehn N, Kist M, et al. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol. 2006;7(3):211\u201322. https:\/\/doi.org\/10.1016\/S1470-2045(06)70586-1.","journal-title":"Lancet Oncol"},{"issue":"2","key":"1678_CR34","doi-asserted-by":"publisher","first-page":"e0170942","DOI":"10.1371\/journal.pone.0170942","volume":"12","author":"KF Tsai","year":"2017","unstructured":"Tsai KF, Liou JM, Chen MJ, Chen CC, Kuo SH, Lai IR, et al. Distinct clinicopathological features and prognosis of Helicobacter pylori negative gastric cancer. PLoS ONE. 2017;12(2):e0170942. https:\/\/doi.org\/10.1371\/journal.pone.0170942.","journal-title":"PLoS ONE"},{"issue":"2","key":"1678_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.mehy.2007.05.045","volume":"70","author":"LJ Xue","year":"2008","unstructured":"Xue LJ, Su QS, Yang JH, Lin Y. Autoimmune responses induced by Helicobacter pylori improve the prognosis of gastric carcinoma. Med Hypotheses. 2008;70(2):273\u20136. https:\/\/doi.org\/10.1016\/j.mehy.2007.05.045.","journal-title":"Med Hypotheses"},{"issue":"1","key":"1678_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12328-016-0696-x","volume":"10","author":"A Okano","year":"2017","unstructured":"Okano A, Kato S, Ohana M. Helicobacter pylori-negative gastric cancer: advanced-stage undifferentiated adenocarcinoma located in the pyloric gland area. Clin J Gastroenterol. 2017;10(1):13\u20137. https:\/\/doi.org\/10.1007\/s12328-016-0696-x.","journal-title":"Clin J Gastroenterol"},{"issue":"12","key":"1678_CR37","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2169\/internalmedicine.0013-17","volume":"57","author":"A Takagi","year":"2018","unstructured":"Takagi A, Ozawa H, Oki M, Yanagi H, Nabeshima K, Nakamura N. Helicobacter pylori-negative advanced gastric cancer with massive eosinophilia. Intern Med. 2018;57(12):1715\u20138. https:\/\/doi.org\/10.2169\/internalmedicine.0013-17.","journal-title":"Intern Med"},{"issue":"5","key":"1678_CR38","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s10120-021-01191-8","volume":"24","author":"M Nikaido","year":"2021","unstructured":"Nikaido M, Kakiuchi N, Miyamoto S, Hirano T, Takeuchi Y, Funakoshi T, et al. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations. Gastric Cancer. 2021;24(5):1102\u201314. https:\/\/doi.org\/10.1007\/s10120-021-01191-8.","journal-title":"Gastric Cancer"},{"key":"1678_CR39","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/1471-2407-10-374","volume":"10","author":"HB Qiu","year":"2010","unstructured":"Qiu HB, Zhang LY, Keshari RP, Wang GQ, Zhou ZW, Xu DZ, et al. Relationship between H. pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer. 2010;10:374. https:\/\/doi.org\/10.1186\/1471-2407-10-374.","journal-title":"BMC Cancer"},{"issue":"4","key":"1678_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5230\/jgc.2010.10.4.168","volume":"10","author":"DW Park","year":"2010","unstructured":"Park DW, Lee KJ, Jin SH, Lee JH, Min JS, Park SH, et al. Phenotypic differences of gastric cancer according to the Helicobacter pylori infection in Korean patients. J Gastric Cancer. 2010;10(4):168\u201374. https:\/\/doi.org\/10.5230\/jgc.2010.10.4.168.","journal-title":"J Gastric Cancer"},{"issue":"2","key":"1678_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2<189::AID-IJC7>3.0.CO;2-Z","volume":"85","author":"JD Hayden","year":"2000","unstructured":"Hayden JD, Cawkwell L, Dixon MF, Pardal F, Murgatroyd H, Gray S, et al. A comparison of microsatellite instability in early onset gastric carcinomas from relatively low and high incidence European populations. Int J Cancer. 2000;85(2):189\u201391.","journal-title":"Int J Cancer"},{"issue":"2","key":"1678_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/mc.23650","volume":"63","author":"S Tahara","year":"2024","unstructured":"Tahara S, Tahara T, Yamazaki J, Shijimaya T, Horiguchi N, Funasaka K, et al. Helicobacter pylori infection associated DNA methylation in primary gastric cancer significantly correlates with specific molecular and clinicopathological features. Mol Carcinog. 2024;63(2):266\u201374. https:\/\/doi.org\/10.1002\/mc.23650.","journal-title":"Mol Carcinog"},{"issue":"3","key":"1678_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/path.6000","volume":"258","author":"K Namikawa","year":"2022","unstructured":"Namikawa K, Tanaka N, Ota Y, Takamatsu M, Kosugi M, Tokai Y, et al. Genomic features of Helicobacter pylori-na\u00efve diffuse-type gastric cancer. J Pathol. 2022;258(3):300\u201311. https:\/\/doi.org\/10.1002\/path.6000.","journal-title":"J Pathol"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01678-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-025-01678-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01678-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:41:08Z","timestamp":1792284068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-025-01678-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1007\/s10120-025-01678-8","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have no conflict of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. The study was approved by the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (No. 2024-0814).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}